GSK Plc (GSK)
51.78
-0.63
(-1.20%)
USD |
NYSE |
Aug 24, 16:00
51.20
-0.58
(-1.12%)
Pre-Market: 05:52
GSK Shareholders Equity (Quarterly) : 23.42B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.42B |
| March 31, 2026 | 23.54B |
| December 31, 2025 | 22.03B |
| September 30, 2025 | 21.74B |
| June 30, 2025 | 20.27B |
| March 31, 2025 | 18.27B |
| December 31, 2024 | 17.12B |
| September 30, 2024 | 18.79B |
| June 30, 2024 | 18.17B |
| March 31, 2024 | 17.48B |
| December 31, 2023 | 17.01B |
| September 30, 2023 | 16.03B |
| June 30, 2023 | 16.13B |
| March 31, 2023 | 14.61B |
| December 31, 2022 | 12.75B |
| September 30, 2022 | 10.22B |
| June 30, 2022 | 19.89B |
| March 31, 2022 | 13.95B |
| December 31, 2021 | 20.39B |
| September 30, 2021 | 20.80B |
| June 30, 2021 | 21.24B |
| March 31, 2021 | 20.51B |
| December 31, 2020 | 19.94B |
| September 30, 2020 | 18.47B |
| June 30, 2020 | 16.80B |
| Date | Value |
|---|---|
| March 31, 2020 | 16.24B |
| December 31, 2019 | 15.11B |
| September 30, 2019 | 14.51B |
| June 30, 2019 | 4.600B |
| March 31, 2019 | 5.230B |
| December 31, 2018 | 5.553B |
| September 30, 2018 | 5.837B |
| June 30, 2018 | 4.857B |
| March 31, 2018 | -96.79M |
| December 31, 2017 | -91.99M |
| September 30, 2017 | 1.736B |
| June 30, 2017 | 1.053B |
| March 31, 2017 | 2.143B |
| December 31, 2016 | 1.389B |
| September 30, 2016 | 179.26M |
| June 30, 2016 | 767.32M |
| March 31, 2016 | 4.036B |
| December 31, 2015 | 7.538B |
| September 30, 2015 | 8.227B |
| June 30, 2015 | 10.73B |
| March 31, 2015 | 11.04B |
| December 31, 2014 | 6.647B |
| September 30, 2014 | 8.175B |
| June 30, 2014 | 10.46B |
| March 31, 2014 | 11.03B |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AstraZeneca PLC | 47.33B |
| Eli Lilly & Co. | 33.88B |
| Merck & Co., Inc. | 41.93B |
| Pfizer Inc. | 85.19B |
| Sanofi | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 81.94B |
| Total Liabilities (Quarterly) | 59.14B |
| Debt to Equity Ratio | 1.034 |
| Current Ratio | 0.8154 |
| Net Debt Paydown Yield | -0.08% |